A similar decrease was also observed here when comparing IL-6 levels in the late stage ME/CFS subgroup (ill for 11 years on average) with the early stage subgroup ill for 2 years or less. The gene discussed is IL6; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.